Histologic Comparison of Ablative Techniques for Endometriosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorTriHealth Inc.
About this trial
To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.
Eligibility criteria
Qualifiers
Adult women 18 years of age or older
Already planning to undergo scheduled robotic assisted or laparoscopic excision of lesions for pelvic pain symptoms (pelvic pain, dysmenorrhea, dyspareunia, dysuria, dyschezia, ovarian pain) or endometriosis of any kind (endometriosis of any location, or endometrioma)
Disqualifiers
Known pregnancy at enrollment or at the time of the excision surgery
Trial design
Treatments tested in this trial
- Diathermy
- CO2 Laser
- Argon Beam Coagulator
Treatment groups
141 Participants
are divided into 3 treatment groupsLocations
1Good Samaritan Hospital45220, CincinnatiOhio, United States
Sponsors and collaborators
TriHealth Inc.
Lead sponsor
Source ClinicalTrials.gov